Connecting Australia’s chemistry researchers with the global bioscience research community.
Compounds Australia provides access to critical infrastructure and expertise to ensure flexible, efficient, reproducible and cost-effective compound management, supporting biological characterisation of compounds throughout the drug discovery pipeline. It manages a national ‘Open’ compound collection, and numerous ‘Closed’ or proprietary compound collections.
Compounds Australia is housed at Griffith Institute of Drug Discovery (GRIDD). GRIDD researchers tackle devastating diseases using Compounds Australia and other unique resources including NatureBank, Australia's largest natural product bio-discovery library stored at Compounds Australia.
Compounds Australia is actively supported by Griffith University through ongoing financial contributions to ensure that an essential piece of Australia's NCRIS infrastructure is made available to global researchers and industry.
Compounds Australia securely stores and curates sample libraries submitted by Australian based chemists. The facility makes these compounds available at low cost in flexible screening and assay-ready formats to academic and not-for-profit researchers.
iLab Operations Software, is an enterprise web-based management tool designed to support operations for centralized labs and shared research resources. Its functionality includes service request and milestone management, sample processing, equipment reservation management, usage tracking, and lab requisitioning. Contact us to generate an account.
Compounds Australia Structure Portal was launched in early 2016 and enables researchers to browse or search the ‘Open’ Compound Collections via a web portal.
CASPeR provides researchers with access to up to date information such as individual chemical properties.
Membership of Compounds Australia is at an organisational level. Being a member of Compounds Australia enables you to access a wide range of services hosted by the facility.
Compounds Australia provides access to critical infrastructure and expertise to ensure flexible, efficient, reproducible and cost-effective compound management supporting biological characterisation of compounds throughout the drug discovery pipeline.
Understanding drug sensitivity in ovarian cancer
"Communication from Compounds Australia was extremely efficient and unambiguous. Importantly, after the primary screen concluded and the end user was looking to validate the key targets, Compounds Australia went above and beyond to identify solutions to a major problem we faced in sourcing sufficient reagents. Without their diligence and commitment, this project would not have been completed as originally anticipated."
Associate Professor Kaylene J. Simpson, Head, Victorian Centre for Functional Genomics
Queensland acoustic compound support could help COVID-19 breakthroughs
05 Jun 2020
The Queensland Government has awarded $1.875 million in funding to Compounds Australia.
GRIDD researchers take next step in COVID-19 vaccine development
30 Mar 2020
Scientists at Griffith University are moving towards animal trials in testing a vaccine candidate...
Griffith awarded $3.3 million in funding for ARC Discovery and Linkage projects
05 Dec 2019
Griffith University has been awarded $3,376,073 for ARC Discovery and Linkage Projects.
Acoustic tech grant a win for Griffith biomedical research
18 Sep 2019
Grant to fund technology that uses sound waves to vibrate chemical samples from acoustic microtube...